funder-graph

FundersMANational Organization for Rare Disorders Inc › 2022

Grants paid by National Organization for Rare Disorders Inc, tax year 2022

EIN 13-3223946 · Danbury, MA · Form 990, Schedule I

In tax year 2022, National Organization for Rare Disorders Inc (EIN 13-3223946) reported 6 grants paid totaling $155,487. Dataset version 2026.09.0, built 2026-09-03.

2019202020212022202320242025

Every grant, 2022

Grants reported by National Organization for Rare Disorders Inc for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Mayo Clinic Rochester Minneapolis, MNA$50,000paidNORSE RESEARCH GRANT AWARD202341319349302394
2022Regents of the University of California Los Angeles, CAA$35,487paidRESEARCH GRANT202341319349302394
2022Cincinnati Children's Hospital Medical Center Cincinnati, OHA$25,000paidNEHI GRANT AWARD202341319349302394
2022University of South Carolina Columbia, SCA$25,000paidACPMP RESEARCH GRANT AWARD202341319349302394
2022H Lee Moffitt Cancer Center & Research Institute Tampa, FLA$12,500paidACPMP RESEARCH GRANT AWARD202341319349302394
2022Baylor College of Medicine Houston, TXA$7,500paidRESEARCH GRANT202341319349302394

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.